WuXi Global Forum 2014

2013 has been a great year in the world of pharma and biotech R&D. While we are still facing mounting productivity challenges, many have come to understand that no single company –...

Winners of WuXi PharmaTech Awards Inducted Into Prestigious Academies

We congratulate five of our former WuXi PharmaTech Life Science and Chemistry Awards winners on their induction as new members of the highly prestigious Chinese Academy of Science (CAS) and Chinese Academy...

WuXi Presents 2013 Life Science and Chemistry Awards

We are delighted to announce that the seventh annual WuXi PharmaTech Life Science and Chemistry Awards ceremony was successfully held on December 7, 2013, at Diaoyutai State Guesthouse in Beijing. Fifteen...

WuXi Partners with Pharmacyclics

Shanghai SynTheAll (STA) Pharmaceutical Co., Ltd., WuXi’s STA, WuXi’s wholly owned subsidiary of small molecule process R&D and manufacturing division, has entered into a supply arrangement with Pharmacyclics, Inc. (Nasdaq: PCYC)....

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Platform for Success: Gossamer Bio’s Quest to Build a Sustainable Company...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) When Celgene bought San Diego-based biotech Receptos for $7.8 billion in 2015, it was...